CRF Health has appointed Jamie Moss as Chief Operating Officer (COO), an aerospace industry veteran who hopes to challenge company paradigms in his new position. Outsourcing-Pharma.com interviewed Jamie to get his perspective on the new role, the eCOA landscape and how it all ties together.
Patient-Centric Research Involving Patients in Clinical Trials Can Lead to Better Outcomes
CRF Health Celebrates American Diabetes Month
American Diabetes Month is important to CRF Health because our mission is to drive innovative medical advancements that enhance and enrich the lives of billions of people worldwide.
eConsent Webinar: About Our Speakers
Learn more about speakers Sandra "SAM" Sather and Giga Smith, presenters of our upcoming webinar: Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites.
DIA 2017 Recap: Wheel of Prizes at CRF Health Booth 2006
10 Steps for Successful Migration of COA from Paper to Electronic
Benefits of a Combined eCOA/eConsent Solution
Understanding the EMA Oncology PRO Guideline Appendix – We Can Help!
2016 eCOA Industry Predictions: BYOD
2016 eCOA Industry Predictions: eCOA Innovations
2016 eCOA Industry Predictions: eCOA Trends
2016 eCOA Industry Predictions: Patient Centricity
eCOA Forum Workshop Recap - Unleashing the Potential of eCOA in Patient-Focused Clinical Trials
eCOA Forum Workshop covering best practices for patients across various therapeutic areas.
eCOA Forum Workshop Recap - User-Centered Design
eCOA Forum Workshop Recap - User Centered Design
eCOA Forum Workshop Recap - Future of BYOD in Clinical Trials
Future of BYOD in clinical trials workshop recap from the 2015 eCOA Forum Scientific Sessions.
Q&A with Dr. John Harrison - Part 4: Technology Advancements in Alzheimer's Trials
This is the final part in the 4-part series written following a Q&A session with Dr. John Harrison.
Q&A with Dr. John Harrison - Part 3: Focus on Raters
This is the third part in the 4-part series written following a Q&A session...
Using the patient perspective to address three main concerns in oncology trials
Although oncology trials account for almost 31% of clinical trials...
Three highlights from the ISPOR 17th Annual European Congress
This year the ISPOR Annual European Congress took place in the...
Q&A with Dr. John Harrison - Part 2: Overcoming the issues
Part 2 - Q&A Session with Dr. John Harrison This is the second part...
Current Problems in Alzheimer’s Clinical Drug Trials